Ewelina Morawa

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor...
- Patent number 12,161,674
- Issue date Dec 10, 2024
- Vertex Pharmaceuticals Incorporated
- Ewelina Morawa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Allogeneic cell therapy of B cell malignancies using genetically en...
- Patent number 11,389,481
- Issue date Jul 19, 2022
- CRISPR THERAPEUTICS AG
- Mark Benton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...
- Publication number 20240115703
- Publication date Apr 11, 2024
- CRISPR Therapeutics AG
- Ziliang LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...
- Publication number 20230220059
- Publication date Jul 13, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...
- Publication number 20220249558
- Publication date Aug 11, 2022
- CRISPR Therapeutics AG
- Mark Benton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CEL...
- Publication number 20220202859
- Publication date Jun 30, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...
- Publication number 20220118019
- Publication date Apr 21, 2022
- CRISPR Therapeutics AG
- Mark Benton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALLOGENEIC CELL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA USING GENET...
- Publication number 20220023344
- Publication date Jan 27, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CHIMERIC ANTIGEN RECEPTOR T CELLS AND NK CELL INHIBITORS FOR...
- Publication number 20220008473
- Publication date Jan 13, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...
- Publication number 20210268026
- Publication date Sep 2, 2021
- CRISPR Therapeutics AG
- Mark Benton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR...
- Publication number 20200384033
- Publication date Dec 10, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Ewelina Morawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ewelina Morawa

Person

Patents Grantslast 30 patents

CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor...

Allogeneic cell therapy of B cell malignancies using genetically en...

Patents Applicationslast 30 patents

GENETICALLY ENGINEERED ANTI-CD19 CAR-T CELLS FOR USE IN TREATING B-...

GENETICALLY ENGINEERED T CELLS EXPRESSING BCMA-SPECIFIC CHIMERIC AN...

ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...

CANCER TREATMENT USING CD38 INHIBITOR AND/OR LENALIDOMIDE AND T-CEL...

ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...

ALLOGENEIC CELL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA USING GENET...

USE OF CHIMERIC ANTIGEN RECEPTOR T CELLS AND NK CELL INHIBITORS FOR...

ALLOGENEIC CELL THERAPY OF B CELL MALIGNANCIES USING GENETICALLY EN...

CRISPR-CAS9 MODIFIED CD34+ HUMAN HEMATOPOIETIC STEM AND PROGENITOR...